Medicine and Dentistry
Human Respiratory Syncytial Virus
92%
Infant
74%
Respiratory Syncytial Virus
54%
Respiratory Tract Infection
51%
Meta-Analysis
46%
Childbirth
31%
Cohort Analysis
31%
Systematic Review
31%
Health Care Cost
22%
Child
19%
Respiratory Syncytial Virus Infection
19%
Surveillance
17%
Age
17%
Odds Ratio
16%
COVID-19
15%
Health
15%
Prospective Cohort Study
15%
Patient
15%
Virus Surveillance
15%
Older Adult
15%
Quality of Life
15%
Respiratory Disease
15%
Bronchiolitis
15%
Global Disease Burden
15%
Toddlers
15%
Prematurity
8%
Learning
7%
Infection
6%
Rhinovirus
5%
Human Metapneumovirus
5%
Disease Burden
5%
Hospital
5%
Inpatient
5%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Birth
31%
Virus
31%
Respiratory Syncytial Virus
19%
Life
18%
Respiratory Syncytial Virus Infection
17%
Human Metapneumovirus
17%
Respiratory Virus
15%
Health
15%
Metagenomics
15%
Coronavirinae
5%
Paramyxovirinae
5%
Rhinovirus
5%
Influenza
5%
Adenoviridae
5%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
52%
Diseases
20%
Respiratory Tract Infection
19%
Respiratory Virus
15%
Pandemic
15%
Cohort Study
15%
Case-Control Study
7%
Paramyxovirinae
5%
Virus
5%
Human Metapneumovirus
5%
Rhinovirus
5%
Influenza
5%